Proteinase K Market Size, Share & Trends Analysis Report By Form (Powder, Liquid), By Therapeutic Area (Infectious Diseases, Neurology, Oncology, Cardiology), By Application, By End-use, By Region, And Segment Forecasts, 2023

The global proteinase K market size is expected to reach USD 7.8 billion by 2030, registering a CAGR of 8.7% during the forecast period. The market growth is fueled by a broad range of applications in molecular diagnostic techniques and their associated enzymes for IVD. Proteinase K can be utilized as a supplement in PCR and NGS. Increasing applications of NGS in personalized medicine along with various clinically developed therapies are likely to favor the market for proteinase K. Gene expression profiling and targeted panels via qPCR remain the two most frequent uses for NGS sequences in a pathology lab. In addition, a decline in the price of NGS sequencing has expanded the use of NSC technologies. Therefore, the growing demand for NGS diagnostic techniques is expected to boost the market growth.

In addition, the rising adoption of cell separation procedures is one of the major factors contributing to the market growth. Companies have initiated building sustainable technologies to gain a competitive edge in the market. For instance, in April 2022, Levitas Bio introduced the next generation of its existing platform for cell separation. The new version is expected to assist researchers in scaling their experiments up to 16X and process around 40 million cells per run.

Moreover, the usage of POC-based diagnostics is increasing significantly globally. Public awareness campaigns aimed at identifying the symptoms of infectious diseases and ways to prevent them play an important role in controlling disease transmission. Thus, increased patient attention has led to a rise in demand for POC. For instance, in May 2020, a study on POC testing for COVID-19 through Specific High Sensitivity Enzymatic Reporter UnLOCKing (SHERLOCK) diagnostics was published. The researchers used QuickExtract by Lucigen, which contains Proteinase K. Thus, the growing demand for POC diagnostics and the utility of proteinase K in POC diagnostic tests are expected to fuel market growth.

Furthermore, growing applications of proteinase K in molecular biology and other fields are expected to create lucrative opportunities in the near future. Proteinase K is used in the food and beverage industry to maintain quality standards. Food manufacturers work to maintain the quality of raw materials used for manufacturing. In addition, proteinase K is used for cell lysis during DNA extraction from processed foods. The enzyme also finds application in a wide range of molecular biology assays. Hence, such applications of proteinase K are anticipated to drive the market during the forecast period.

Proteinase K Market Report Highlights

By form, the powder segment accounted for a dominant share in 2022. Advantages of powder form include long shelf-life, inexpensive shipment, and high stability. Thus, such advantages are expected to increase the adoption of powder
By therapeutic area, the infectious diseases segment captured the largest share in 2022. Presence of proteinase K in the rapid molecule testing along with increasing incidence of infectious diseases in low- to mid-income countries is anticipated to encourage players to develop products that are easy to operate in a low-resource setting. This is, in turn, accelerating the market growth
By application, the isolation and purification of genomic DNA and RNA segment held the largest share in 2022. With the emerging need for personalized treatment in cancer and rare diseases, the demand for DNA or RNA isolation is anticipated to witness upward trends and similar trends will be reflected in the market
By end-use, biotechnology companies held a leading revenue share in 2022. This is due to an increase in the application of In Situ Hybridization (ISH) techniques to support clinical and preclinical studies for biotechnology companies
North America occupied the largest market share in 2022 and is expected to maintain its lead over the forecast period owing to the high demand for proteinase K and the increasing prevalence of infectious diseases in the region
Asia Pacific is projected to grow considerably in the future owing to increasing applications of sequencing technology, coupled with various government initiatives to promote genomics research.

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.1.1. Form
1.1.2. Therapeutic area
1.1.3. End use
1.1.4. Application
1.1.5. Regional scope
1.1.6. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Form outlook
2.2.2. Therapeutic area outlook
2.2.3. End use outlook
2.2.4. Application outlook
2.2.5. Regional outlook
2.3. Competitive Insights

Chapter 3. Proteinase K Market Variables, Trends & Scope

3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Proteinase K Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape

Chapter 4. Proteinase K: Form Estimates & Trend Analysis

4.1. Proteinase K Market: Key Takeaways
4.2. Proteinase K Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Powder
4.3.1. Powder market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Liquid
4.4.1. Liquid market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Proteinase K: Therapeutic Area Estimates & Trend Analysis

5.1. Proteinase K Market: Key Takeaways
5.2. Proteinase K Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Infectious Diseases
5.3.1. Infectious diseases market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Diabetes
5.4.1. Diabetes market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Oncology
5.5.1. Oncology market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Cardiology
5.6.1. Cardiology market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Nephrology
5.7.1. Nephrology market estimates and forecasts, 2018 to 2030 (USD Million)
5.8. Autoimmune Diseases
5.8.1. Autoimmune diseases market estimates and forecasts, 2018 to 2030 (USD Million)
5.9. Neurology
5.9.1. Neurology market estimates and forecasts, 2018 to 2030 (USD Million)
5.10. Others
5.10.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Proteinase K: End Use Estimates & Trend Analysis

6.1. Proteinase K Market: Key Takeaways
6.2. Proteinase K Market: Movement & Market Share Analysis, 2022 & 2030
6.3. Isolation and Purification of Genomic DNA & RNA
6.3.1. Isolation and purification of genomic DNA & RNA market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. In Situ Hybridization
6.4.1. In situ hybridization market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Mitochondria Isolation
6.5.1. Mitochondria isolation market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Proteinase K: Application Estimates & Trend Analysis

7.1. Proteinase K Market: Key Takeaways
7.2. Proteinase K Market: Movement & Market Share Analysis, 2022 & 2030
7.3. Contract Research Organization
7.3.1. Contract research organization market estimates and forecasts, 2018 to 2030 (USD Million)
7.4. Academic Institutes
7.4.1. Academic institutes market estimates and forecasts, 2018 to 2030 (USD Million)
7.5. Biotechnology Companies
7.5.1. Biotechnology companies market estimates and forecasts, 2018 to 2030 (USD Million)
7.6. Diagnostic Laboratories
7.6.1. Diagnostic laboratories market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Proteinase K Market: Regional Estimates & Trend Analysis

8.1. Regional Outlook
8.2. Proteinase K Market by Region: Key Takeaways
8.3. North America
8.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.3.2. U.S.
8.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.3.3. Canada
8.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.4. Europe
8.4.1. UK
8.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.4.2. Germany
8.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.4.3. France
8.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.4.4. Italy
8.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.4.5. Spain
8.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.4.6. Denmark
8.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.4.7. Sweden
8.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.4.8. Norway
8.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.5. Asia Pacific
8.5.1. Japan
8.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.5.2. China
8.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.5.3. India
8.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.5.4. Australia
8.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.5.5. Thailand
8.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.5.6. South Korea
8.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.6. Latin America
8.6.1. Brazil
8.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.6.2. Mexico
8.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.6.3. Argentina
8.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.7. MEA
8.7.1. South Africa
8.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.7.2. Saudi Arabia
8.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.7.3. UAE
8.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.7.4. Kuwait
8.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 9. Competitive Landscape

9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Market Participant Categorization
9.2.1. Merck KGaA
9.2.1.1. Company overview
9.2.1.2. Financial performance
9.2.1.3. Product benchmarking
9.2.1.4. Strategic initiatives
9.2.2. QIAGEN
9.2.2.1. Company overview
9.2.2.2. Financial performance
9.2.2.3. Product benchmarking
9.2.2.4. Strategic initiatives
9.2.3. Thermo Fisher Scientific, Inc.
9.2.3.1. Company overview
9.2.3.2. Financial performance
9.2.3.3. Product benchmarking
9.2.3.4. Strategic initiatives
9.2.4. F. Hoffmann-La Roche Ltd
9.2.4.1. Company overview
9.2.4.2. Financial performance
9.2.4.3. Product benchmarking
9.2.4.4. Strategic initiatives
9.2.5. Abcam plc.
9.2.5.1. Company overview
9.2.5.2. Financial performance
9.2.5.3. Product benchmarking
9.2.5.4. Strategic initiatives
9.2.6. Agilent Technologies, Inc.
9.2.6.1. Company overview
9.2.6.2. Financial performance
9.2.6.3. Product benchmarking
9.2.6.4. Strategic initiatives
9.2.7. Biocatalysts
9.2.7.1. Company overview
9.2.7.2. Financial performance
9.2.7.3. Product benchmarking
9.2.7.4. Strategic initiatives
9.2.8. Minerva Biolabs GmbH
9.2.8.1. Company overview
9.2.8.2. Financial performance
9.2.8.3. Product benchmarking
9.2.8.4. Strategic initiatives
9.2.9. Promega Corporation
9.2.9.1. Company overview
9.2.9.2. Financial performance
9.2.9.3. Product benchmarking
9.2.9.4. Strategic initiatives
9.2.10. Takara Bio Inc.
9.2.10.1. Company overview
9.2.10.2. Financial performance
9.2.10.3. Product benchmarking
9.2.10.4. Strategic initiatives
9.2.11. New England Biolabs
9.2.11.1. Company overview
9.2.11.2. Financial performance
9.2.11.3. Product benchmarking
9.2.11.4. Strategic initiatives
9.2.12. MP BIOMEDICALS.
9.2.12.1. Company overview
9.2.12.2. Financial performance
9.2.12.3. Product benchmarking
9.2.12.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviation
Table 2 North America proteinase K market, by form, 2018 - 2030 (USD Million)
Table 3 North America proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 4 North America proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 5 North America proteinase K market, by application, 2018 - 2030 (USD Million)
Table 6 North America proteinase K market, by region, 2018 - 2030 (USD Million)
Table 7 U.S. proteinase K market, by form, 2018 - 2030 (USD Million)
Table 8 U.S. proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 9 U.S. proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 10 U.S. proteinase K market, by application, 2018 - 2030 (USD Million)
Table 11 Canada proteinase K market, by form, 2018 - 2030 (USD Million)
Table 12 Canada proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 13 Canada proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 14 Canada proteinase K market, by application, 2018 - 2030 (USD Million)
Table 15 Europe proteinase K market, by form, 2018 - 2030 (USD Million)
Table 16 Europe proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 17 Europe proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 18 Europe proteinase K market, by application, 2018 - 2030 (USD Million)
Table 19 Europe proteinase K market, by region, 2018 - 2030 (USD Million)
Table 20 UK proteinase K market, by form, 2018 - 2030 (USD Million)
Table 21 UK proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 22 UK proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 23 UK proteinase K market, by application, 2018 - 2030 (USD Million)
Table 24 Germany proteinase K market, by form, 2018 - 2030 (USD Million)
Table 25 Germany proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 26 Germany proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 27 Germany proteinase K market, by application, 2018 - 2030 (USD Million)
Table 28 France proteinase K market, by form, 2018 - 2030 (USD Million)
Table 29 France proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 30 France proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 31 France proteinase K market, by application, 2018 - 2030 (USD Million)
Table 32 Italy proteinase K market, by form, 2018 - 2030 (USD Million)
Table 33 Italy proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 34 Italy proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 35 Italy proteinase K market, by application, 2018 - 2030 (USD Million)
Table 36 Spain proteinase K market, by form, 2018 - 2030 (USD Million)
Table 37 Spain proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 38 Spain proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 39 Spain proteinase K market, by application, 2018 - 2030 (USD Million)
Table 40 Denmark proteinase K market, by form, 2018 - 2030 (USD Million)
Table 41 Denmark proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 42 Denmark proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 43 Denmark proteinase K market, by application, 2018 - 2030 (USD Million)
Table 44 Sweden proteinase K market, by form, 2018 - 2030 (USD Million)
Table 45 Sweden proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 46 Sweden proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 47 Sweden proteinase K market, by application, 2018 - 2030 (USD Million)
Table 48 Norway proteinase K market, by form, 2018 - 2030 (USD Million)
Table 49 Norway proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 50 Norway proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 51 Norway proteinase K market, by application, 2018 - 2030 (USD Million)
Table 52 Asia Pacific proteinase K market, by form, 2018 - 2030 (USD Million)
Table 53 Asia Pacific proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 54 Asia Pacific proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 55 Asia Pacific proteinase K market, by application, 2018 - 2030 (USD Million)
Table 56 Asia Pacific proteinase K market, by region, 2018 - 2030 (USD Million)
Table 57 Japan proteinase K market, by form, 2018 - 2030 (USD Million)
Table 58 Japan proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 59 Japan proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 60 Japan proteinase K market, by application, 2018 - 2030 (USD Million)
Table 61 China proteinase K market, by form, 2018 - 2030 (USD Million)
Table 62 China proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 63 China proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 64 China proteinase K market, by application, 2018 - 2030 (USD Million)
Table 65 India proteinase K market, by form, 2018 - 2030 (USD Million)
Table 66 India proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 67 India proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 68 India proteinase K market, by application, 2018 - 2030 (USD Million)
Table 69 Australia proteinase K market, by form, 2018 - 2030 (USD Million)
Table 70 Australia proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 71 Australia proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 72 Australia proteinase K market, by application, 2018 - 2030 (USD Million)
Table 73 Thailand proteinase K market, by form, 2018 - 2030 (USD Million)
Table 74 Thailand proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 75 Thailand proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 76 Thailand proteinase K market, by application, 2018 - 2030 (USD Million)
Table 77 South Korea proteinase K market, by form, 2018 - 2030 (USD Million)
Table 78 South Korea proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 79 South Korea proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 80 South Korea proteinase K market, by application, 2018 - 2030 (USD Million)
Table 81 Latin America proteinase K market, by form, 2018 - 2030 (USD Million)
Table 82 Latin America proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 83 Latin America proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 84 Latin America proteinase K market, by application, 2018 - 2030 (USD Million)
Table 85 Latin America proteinase K market, by region, 2018 - 2030 (USD Million)
Table 86 Brazil proteinase K market, by form, 2018 - 2030 (USD Million)
Table 87 Brazil proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 88 Brazil proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 89 Brazil proteinase K market, by application, 2018 - 2030 (USD Million)
Table 90 Mexico proteinase K market, by form, 2018 - 2030 (USD Million)
Table 91 Mexico proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 92 Mexico proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 93 Mexico proteinase K market, by application, 2018 - 2030 (USD Million)
Table 94 Argentina proteinase K market, by form, 2018 - 2030 (USD Million)
Table 95 Argentina proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 96 Argentina proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 97 Argentina proteinase K market, by application, 2018 - 2030 (USD Million)
Table 98 Middle East and Africa proteinase K market, by form, 2018 - 2030 (USD Million)
Table 99 Middle East and Africa proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 100 Middle East and Africa proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 101 Middle East and Africa proteinase K market, by application, 2018 - 2030 (USD Million)
Table 102 Middle East and Africa proteinase K market, by region, 2018 - 2030 (USD Million)
Table 103 South Africa proteinase K market, by form, 2018 - 2030 (USD Million)
Table 104 South Africa proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 105 South Africa proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 106 South Africa proteinase K market, by application, 2018 - 2030 (USD Million)
Table 107 Saudi Arabia proteinase K market, by form, 2018 - 2030 (USD Million)
Table 108 Saudi Arabia proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 109 Saudi Arabia proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 110 Saudi Arabia proteinase K market, by application, 2018 - 2030 (USD Million)
Table 111 UAE proteinase K market, by form, 2018 - 2030 (USD Million)
Table 112 UAE proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 113 UAE proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 114 UAE proteinase K market, by application, 2018 - 2030 (USD Million)
Table 115 Kuwait proteinase K market, by form, 2018 - 2030 (USD Million)
Table 116 Kuwait proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 117 Kuwait proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 118 Kuwait proteinase K market, by application, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Proteinase K: Market outlook
Fig. 9 Proteinase K: Competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Proteinase K market driver impact
Fig. 15 Proteinase K market restraint impact
Fig. 16 Proteinase K market strategic initiatives analysis
Fig. 17 Proteinase K market: Form movement analysis
Fig. 18 Proteinase K market: Form outlook and key takeaways
Fig. 19 Powder market estimates and forecasts, 2018 - 2030
Fig. 20 Liquid market estimates and forecasts, 2018 - 2030
Fig. 21 Proteinase K market: Therapeutic area movement analysis
Fig. 22 Proteinase K market: Therapeutic area outlook and key takeaways
Fig. 23 Infectious diseases market estimates and forecasts, 2018 - 2030
Fig. 24 Diabetes market estimates and forecasts, 2018 - 2030
Fig. 25 Oncology market estimates and forecasts, 2018 - 2030
Fig. 26 Cardiology market estimates and forecasts, 2018 - 2030
Fig. 27 Nephrology market estimates and forecasts, 2018 - 2030
Fig. 28 Autoimmune diseases market estimates and forecasts, 2018 - 2030
Fig. 29 Neurology market estimates and forecasts, 2018 - 2030
Fig. 30 Others market estimates and forecasts, 2018 - 2030
Fig. 31 Proteinase K market: Application movement analysis
Fig. 32 Proteinase K market: Application outlook and key takeaways
Fig. 33 Isolation and purification of genomic DNA & RNA market estimates and forecasts, 2018 - 2030
Fig. 34 In situ hybridization market estimates and forecasts, 2018 - 2030
Fig. 35 Mitochondria isolation market estimates and forecasts, 2018 - 2030
Fig. 36 Proteinase K market: End use movement analysis
Fig. 37 Proteinase K market: End use outlook and key takeaways
Fig. 38 Contract research organization market estimates and forecasts, 2018 - 2030
Fig. 39 Academic institutes market estimates and forecasts, 2018 - 2030
Fig. 40 Biotechnology companies market estimates and forecasts, 2018 - 2030
Fig. 41 Diagnostic laboratories market estimates and forecasts, 2018 - 2030
Fig. 42 Global proteinase K market: Regional movement analysis
Fig. 43 Global proteinase K market: Regional outlook and key takeaways
Fig. 44 North America market estimates and forecasts, 2018 - 2030
Fig. 45 U.S. market estimates and forecasts, 2018 - 2030
Fig. 46 Canada market estimates and forecasts, 2018 - 2030
Fig. 47 Europe market estimates and forecasts, 2018 - 2030
Fig. 48 UK market estimates and forecasts, 2018 - 2030
Fig. 49 Germany market estimates and forecasts, 2018 - 2030
Fig. 50 France market estimates and forecasts, 2018 - 2030
Fig. 51 Italy market estimates and forecasts, 2018 - 2030
Fig. 52 Spain market estimates and forecasts, 2018 - 2030
Fig. 53 Denmark market estimates and forecasts, 2018 - 2030
Fig. 54 Sweden market estimates and forecasts, 2018 - 2030
Fig. 55 Norway market estimates and forecasts, 2018 - 2030
Fig. 56 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 57 Japan market estimates and forecasts, 2018 - 2030
Fig. 58 China market estimates and forecasts, 2018 - 2030
Fig. 59 India market estimates and forecasts, 2018 - 2030
Fig. 60 Australia market estimates and forecasts, 2018 - 2030
Fig. 61 Thailand market estimates and forecasts, 2018 - 2030
Fig. 62 South Korea market estimates and forecasts, 2018 - 2030
Fig. 63 Latin America market estimates and forecasts, 2018 - 2030
Fig. 64 Brazil market estimates and forecasts, 2018 - 2030
Fig. 65 Mexico market estimates and forecasts, 2018 - 2030
Fig. 66 Argentina market estimates and forecasts, 2018 - 2030
Fig. 67 Middle East and Africa. market estimates and forecasts, 2018 - 2030
Fig. 68 South Africa market estimates and forecasts, 2018 - 2030
Fig. 69 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 70 UAE market estimates and forecasts, 2018 - 2030
Fig. 71 Kuwait market estimates and forecasts, 2018 - 2030

Companies Mentioned

Merck KGaA
QIAGEN
Thermo Fisher Scientific, Inc.
F. Hoffmann-La Roche Ltd
Abcam plc.
Agilent Technologies, Inc.
Biocatalysts
Minerva Biolabs GmbH
Promega Corporation
Takara Bio Inc.
New England Biolabs
MP BIOMEDICALS.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	150
Published	September 2023
Forecast Period	2022 - 2030
Estimated Market Value ( USD ) in 2022	$ 4 Billion
Forecasted Market Value ( USD ) by 2030	$ 7.8 Billion
Compound Annual Growth Rate	8.7%
Regions Covered	Global
No. of Companies Mentioned	12

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€5917EUR$5,950USD£4,910GBP
1 - 5 USER LICENSE PDF	The product is a PDF.	This is a 1-5 user license, allowing up to five users have access to the product.	€6911EUR$6,950USD£5,736GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€8900EUR$8,950USD£7,386GBP

Proteinase K Market Size, Share & Trends Analysis Report By Form (Powder, Liquid), By Therapeutic Area (Infectious Diseases, Neurology, Oncology, Cardiology), By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030

Proteinase K Market Report Highlights

Table of Contents

Companies Mentioned

Methodology

Table Information

Proteinase K Market Report Highlights

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Proteinase K Market by Therapeutic Area, Form - Global Forecast 2025-2030

Proteinase K Market Report: Trends, Forecast and Competitive Analysis to 2030

Proteinase K Global Market Report 2024

Proteinase K - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

Proteinase K Market Outlook Report: Industry Size, Competition, Trends and Growth Opportunities by Region, YoY Forecasts from 2024 to 2031